Review



cd40l  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems cd40l
    Glioblastoma (GBM) secretes <t>CD40L</t> to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001
    Cd40l, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/Human+CD40+Ligand%2FTNFSF5+Quantikine+ELISA+Kit/pmc09339241-60-27-29
    Average 93 stars, based on 21 article reviews
    cd40l - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment"

    Article Title: Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment

    Journal: Clinical and Translational Medicine

    doi: 10.1002/ctm2.997

    Glioblastoma (GBM) secretes CD40L to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001
    Figure Legend Snippet: Glioblastoma (GBM) secretes CD40L to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001

    Techniques Used: Expressing, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Incubation, Transfection, Staining

    CD40L increased LOX expression via CD40‐mediated NF‐κB2 nucleus translocation. (A) Western blot analysis to determine CD40 downstream effector activation status in MSLCs treated with control conditioned medium (CM) or X01 CM. (B) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of LOX expression in MSLCs transfected with siRNA as indicated. (C) Western blot analysis of the nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM in the cytosol‐nuclear fraction of MSLCs. (D) Immunocytochemistry in MSLCs and nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM. Scale bar: 50 μm. (E) qRT‐PCR of LOX expression in MSLCs treated with X01 CM and transfected with siRNA as indicated. (F) Enzyme‐linked immunosorbent assay of LOX in CM after co‐culture with each transfected cell type. (G) Western blots of fractionated lysates of MSLCs transfected with siRNA‐control or si‐ CD40 after co‐culture with X01. (H) Nuclear translocation of NF‐κB2 in MSLC siRNA‐control or MSLC si‐ CD40 treated or not treated with X01 CM. Scale bar: 50 μm. (I) Chromatin immunoprecipitation for assessing NF‐κB2 binding to LOX promoter in MSLCs. (J) Representative image of 3D collagen‐based matrix pre‐incubated with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 and/or X01 cells stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Bottom graph shows collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (K) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. ** p < .01, *** p < .001, **** p < .0001
    Figure Legend Snippet: CD40L increased LOX expression via CD40‐mediated NF‐κB2 nucleus translocation. (A) Western blot analysis to determine CD40 downstream effector activation status in MSLCs treated with control conditioned medium (CM) or X01 CM. (B) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of LOX expression in MSLCs transfected with siRNA as indicated. (C) Western blot analysis of the nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM in the cytosol‐nuclear fraction of MSLCs. (D) Immunocytochemistry in MSLCs and nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM. Scale bar: 50 μm. (E) qRT‐PCR of LOX expression in MSLCs treated with X01 CM and transfected with siRNA as indicated. (F) Enzyme‐linked immunosorbent assay of LOX in CM after co‐culture with each transfected cell type. (G) Western blots of fractionated lysates of MSLCs transfected with siRNA‐control or si‐ CD40 after co‐culture with X01. (H) Nuclear translocation of NF‐κB2 in MSLC siRNA‐control or MSLC si‐ CD40 treated or not treated with X01 CM. Scale bar: 50 μm. (I) Chromatin immunoprecipitation for assessing NF‐κB2 binding to LOX promoter in MSLCs. (J) Representative image of 3D collagen‐based matrix pre‐incubated with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 and/or X01 cells stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Bottom graph shows collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (K) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. ** p < .01, *** p < .001, **** p < .0001

    Techniques Used: Expressing, Translocation Assay, Western Blot, Activation Assay, Control, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Immunocytochemistry, Enzyme-linked Immunosorbent Assay, Co-Culture Assay, Chromatin Immunoprecipitation, Binding Assay, Incubation, Staining, Cell Culture

    CD40L neutralizing antibody and knockdown of CD40 suppressed ECM remodelling and GBM infiltration. (A) Schematic illustration of GBM model generation and the overall therapeutic procedure for orthotopic xenograft animal model. (B) H&E and ZEB1 staining of coronally sectioned mouse brain. Yellow dash represents tumour margin. Red triangles represent ZEB1‐positive infiltration cells ( n = 6 mouse/group). Scale bar: 100 μm. (C) The number of ZEB1‐positive cells infiltrated outside the tumour margin in (B). (D) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of CD40L , CD40 and LOX expression in mouse brain tissue ( n = 3 mouse/group). (E) IHC of CD40, CD40L, NFκB2 and LOX in the indicated groups ( n = 6 mouse/group). Scale bar: 100 μm. (F) Representative image of Picrosirius red‐stained mouse brain tissue for each xenograft group. Collagen fibre area = polarized area/total area ( n = 6 mouse/group). Collagen fibre area (right) = polarized area/total area ( n = 6 mouse/group). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. *** p < .001, **** p < .0001
    Figure Legend Snippet: CD40L neutralizing antibody and knockdown of CD40 suppressed ECM remodelling and GBM infiltration. (A) Schematic illustration of GBM model generation and the overall therapeutic procedure for orthotopic xenograft animal model. (B) H&E and ZEB1 staining of coronally sectioned mouse brain. Yellow dash represents tumour margin. Red triangles represent ZEB1‐positive infiltration cells ( n = 6 mouse/group). Scale bar: 100 μm. (C) The number of ZEB1‐positive cells infiltrated outside the tumour margin in (B). (D) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of CD40L , CD40 and LOX expression in mouse brain tissue ( n = 3 mouse/group). (E) IHC of CD40, CD40L, NFκB2 and LOX in the indicated groups ( n = 6 mouse/group). Scale bar: 100 μm. (F) Representative image of Picrosirius red‐stained mouse brain tissue for each xenograft group. Collagen fibre area = polarized area/total area ( n = 6 mouse/group). Collagen fibre area (right) = polarized area/total area ( n = 6 mouse/group). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. *** p < .001, **** p < .0001

    Techniques Used: Knockdown, Animal Model, Staining, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Expressing

    Correlation between tumour MSLC‐isolatable patients and clinical outcome. (A) IHC of LOX, COL1A1, CD40L, CD40 and NF‐κB2 in MSLC‐isolatable ( n = 4) and MSLC‐non‐isolatable ( n = 4) patient samples. Scale bar: 100 μm. (B) Picrosirius red‐stained MSLC‐isolatable ( n = 3) and MSLC‐non‐isolatable ( n = 3) GBM patient samples. Image: collagen fibre (top, polarized light) and analysis of polarized area (bottom). Graph shows collagen fibre area = polarized area/total area ( n = 3). (C) Gene set enrichment analysis (GSEA) of MSLC‐isolatable and non‐isolatable patients. Analysis of gene set related to ECM‐cell adhesion by each GBM subtype. (D) Kaplan–Meier survival curves of all glioma patients (REMBRANDT) with fixed high or low LOX and COL1A1 median expression. (E) GSEA of all GBMLGG patients with high and low median LOX expression. (F) GBM subtype‐specific expression of the indicated genes in patients with GBM in The Cancer Genome Atlas (TCGA). (G) Two‐gene scatter plots of the indicated genes in patients with glioma in TCGA. (H) Kaplan–Meier survival curves of all glioma patients (TCGA) with high or low indicated median expression of gene. (I) Schematic summarizing promotion of ECM remodelling and GBM infiltration by GBM‐educated MSLCs in the tumour microenvironment. n.s. = not significant, * p < .05, ** p < .01, **** p < .0001
    Figure Legend Snippet: Correlation between tumour MSLC‐isolatable patients and clinical outcome. (A) IHC of LOX, COL1A1, CD40L, CD40 and NF‐κB2 in MSLC‐isolatable ( n = 4) and MSLC‐non‐isolatable ( n = 4) patient samples. Scale bar: 100 μm. (B) Picrosirius red‐stained MSLC‐isolatable ( n = 3) and MSLC‐non‐isolatable ( n = 3) GBM patient samples. Image: collagen fibre (top, polarized light) and analysis of polarized area (bottom). Graph shows collagen fibre area = polarized area/total area ( n = 3). (C) Gene set enrichment analysis (GSEA) of MSLC‐isolatable and non‐isolatable patients. Analysis of gene set related to ECM‐cell adhesion by each GBM subtype. (D) Kaplan–Meier survival curves of all glioma patients (REMBRANDT) with fixed high or low LOX and COL1A1 median expression. (E) GSEA of all GBMLGG patients with high and low median LOX expression. (F) GBM subtype‐specific expression of the indicated genes in patients with GBM in The Cancer Genome Atlas (TCGA). (G) Two‐gene scatter plots of the indicated genes in patients with glioma in TCGA. (H) Kaplan–Meier survival curves of all glioma patients (TCGA) with high or low indicated median expression of gene. (I) Schematic summarizing promotion of ECM remodelling and GBM infiltration by GBM‐educated MSLCs in the tumour microenvironment. n.s. = not significant, * p < .05, ** p < .01, **** p < .0001

    Techniques Used: Staining, Expressing

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Incorporation of CD40 Ligand into the Envelope of Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Enhances Immunogenicity
    Article Snippet: .. A p27 ELISA kit (Beckman Coulter, Fullerton, CA) was used to measure the Gag p27 concentration, and a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) was used to measure the CD40L concentration, as described in the manufacturer's protocol. ..

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Increased circulating soluble LR11 in patients with acute coronary syndrome.
    Article Snippet: Contents lists available at SciVerse ScienceDirect Clinica Chimica Acta j ourna l homepage: www.e lsev ie r .com/ locate /c l inch im Increased circulating soluble LR11 in patients with acute coronary syndrome Manabu Ogita a, Katsumi Miyauchi a,⁎, Tomotaka Dohi a, Shuta Tsuboi a, Tadashi Miyazaki a, Takayuki Yokoyama a, Ken Yokoyama a, Kazunori Shimada a, Takeshi Kurata a, Meizi Jiang b, Hideaki Bujo b, Hiroyuki Daida a a Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan b Department of Genome Research and Clinical Investigation, Chiba University Graduate School of Medicine, Chiba, Japan Abbreviations: ACS, acute coronary syndrome; CRP, taneous coronary intervention; SAP, stable angina pecto STEMI, ST-segment elevation myocardial infarction; UAP, urokinase-type plasminogen activator.. ⁎ Corresponding author at: Department of Cardiovascula Graduate School ofMedicine, 2-1-1Hongo, Bunkyo-ku, Tok 3813 3111; fax: +81 3 5689 0627.. E-mail address: ktmmy@med.juntendo.ac.jp (K. Miy 0009-8981/$ – see front matter © 2012 Elsevier B.V. All http://dx.doi.org/10.1016/j.cca.2012.10.047 a b s t r a c t a r t i c l e i n f o Article history: Received 31 August 2012 Received in revised form 29 October 2012 Accepted 29 October 2012 Available online 2 November 2012 Keywords: LR11 Smooth muscle cell Biomarker Acute coronary syndrome Background: LR11 (also so called SorLA or SORL1) is a novel marker of intimal smooth muscle cell (SMC) proliferation.

    Article Title: Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
    Article Snippet: .. sCD40L was measured in plasma and CeSF samples derived from HIV1-infected individuals using a human CD40L ELISA kit (R&D Systems) and methods outlined previously (32, 34). ..

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. ELISA sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals
    Article Snippet: .. Soluble CD40L was measured in plasma samples derived from HIV infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) treated with antiretrovirals (5 μM of each drug in combinations indicated in the figures) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier . ..

    Concentration Assay:

    Article Title: Incorporation of CD40 Ligand into the Envelope of Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Enhances Immunogenicity
    Article Snippet: .. A p27 ELISA kit (Beckman Coulter, Fullerton, CA) was used to measure the Gag p27 concentration, and a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) was used to measure the CD40L concentration, as described in the manufacturer's protocol. ..

    Clinical Proteomics:

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
    Article Snippet: .. sCD40L was measured in plasma and CeSF samples derived from HIV1-infected individuals using a human CD40L ELISA kit (R&D Systems) and methods outlined previously (32, 34). ..

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. ELISA sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals
    Article Snippet: .. Soluble CD40L was measured in plasma samples derived from HIV infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) treated with antiretrovirals (5 μM of each drug in combinations indicated in the figures) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier . ..

    Derivative Assay:

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.
    Article Snippet: .. sCD40L was measured in plasma and CeSF samples derived from HIV1-infected individuals using a human CD40L ELISA kit (R&D Systems) and methods outlined previously (32, 34). ..

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. ELISA sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals
    Article Snippet: .. Soluble CD40L was measured in plasma samples derived from HIV infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) treated with antiretrovirals (5 μM of each drug in combinations indicated in the figures) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier . ..

    Infection:

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. ELISA sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals
    Article Snippet: .. Soluble CD40L was measured in plasma samples derived from HIV infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) treated with antiretrovirals (5 μM of each drug in combinations indicated in the figures) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier . ..

    Purification:

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Anti-platelet activity of valproic acid contributes to decreased soluble CD40L production in human immunodeficiency virus type 1-infected individuals
    Article Snippet: .. ELISA sCD40L was measured in plasma samples derived from HIV-1 infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier ( 14 ). ..

    Article Title: Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals
    Article Snippet: .. Soluble CD40L was measured in plasma samples derived from HIV infected individuals or supernatants from purified human platelets (9×10 7 cells/sample) treated with antiretrovirals (5 μM of each drug in combinations indicated in the figures) using a human CD40L ELISA kit (R&D Systems, Minneapolis, MN) as outlined earlier . ..



    Similar Products

    90
    Thermo Fisher cd40l (soluble) human elisa kit bms239
    Cd40l (Soluble) Human Elisa Kit Bms239, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/anti+f4+80/pm39576490-58-14-26
    Average 90 stars, based on 1 article reviews
    cd40l (soluble) human elisa kit bms239 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher human cd40l (soluble) elisa kit
    Human Cd40l (Soluble) Elisa Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/pm38922882-69-28-33
    Average 90 stars, based on 1 article reviews
    human cd40l (soluble) elisa kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc human cd40l elisa kit tnfsf5 ab196268
    Human Cd40l Elisa Kit Tnfsf5 Ab196268, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/pm37892436-93-1-7
    Average 86 stars, based on 1 article reviews
    human cd40l elisa kit tnfsf5 ab196268 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    91
    Diaclone human scd40l elisa kit
    Human Scd40l Elisa Kit, supplied by Diaclone, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/Human+CD40L+ELISA+Kit/10__12659_slash_msm__941109-72-40-48
    Average 91 stars, based on 1 article reviews
    human scd40l elisa kit - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    86
    Danaher Inc human cd40l elisa kit
    Angiogenesis-related factors between RIC group and the control group. *P < 0.05. P values were calculated by Mann-Whitney U test. Data are expressed as median with interquartile range (IQR). <t>CD40L</t> indicates CD40 ligand; EGF, epidermal growth factor; PDGF, platelet-derived growth factor; RIC, remote ischemic conditioning; VEGF, vascular endothelial growth factor.
    Human Cd40l Elisa Kit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/pmc10627541-142-28-33
    Average 86 stars, based on 1 article reviews
    human cd40l elisa kit - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    93
    R&D Systems cd40l
    Glioblastoma (GBM) secretes <t>CD40L</t> to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001
    Cd40l, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/Human+CD40+Ligand%2FTNFSF5+Quantikine+ELISA+Kit/pmc09339241-60-27-29
    Average 93 stars, based on 1 article reviews
    cd40l - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems cd40l assay
    Glioblastoma (GBM) secretes <t>CD40L</t> to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001
    Cd40l Assay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/Human+CD40+Ligand%2FTNFSF5+Quantikine+ELISA+Kit/pm34839148-44-1-3
    Average 93 stars, based on 1 article reviews
    cd40l assay - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    RayBiotech inc human cd40l elisa kit (elh-cd40l)
    Expression of <t>CD40L</t> and 4-1BBL on Mel526 cells Mel526 cells infected with LOAd700 or LOAd703 express CD40L (upper histograms), while cells infected with LOAd703 also present 4-1BBL (lower histograms), as shown with flow cytometry at day 2 post-infection. Gray and black histograms represent isotype control and transgene staining, respectively.
    Human Cd40l Elisa Kit (Elh Cd40l), supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd40l+elisa+kit/an+enzyme+linked+immunosorbent+assay+kit+for+cd40l/pmc07940707-208-5-17
    Average 90 stars, based on 1 article reviews
    human cd40l elisa kit (elh-cd40l) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Angiogenesis-related factors between RIC group and the control group. *P < 0.05. P values were calculated by Mann-Whitney U test. Data are expressed as median with interquartile range (IQR). CD40L indicates CD40 ligand; EGF, epidermal growth factor; PDGF, platelet-derived growth factor; RIC, remote ischemic conditioning; VEGF, vascular endothelial growth factor.

    Journal: The Neurologist

    Article Title: Remote Ischemic Conditioning for Motor Recovery after Acute Ischemic Stroke

    doi: 10.1097/NRL.0000000000000498

    Figure Lengend Snippet: Angiogenesis-related factors between RIC group and the control group. *P < 0.05. P values were calculated by Mann-Whitney U test. Data are expressed as median with interquartile range (IQR). CD40L indicates CD40 ligand; EGF, epidermal growth factor; PDGF, platelet-derived growth factor; RIC, remote ischemic conditioning; VEGF, vascular endothelial growth factor.

    Article Snippet: The following ELISA kits were used: Human EGF ELISA Kit (KE00138, Proteintech, USA), Human PDGF-BB ELISA Kit (KE00161, Proteintech, USA), AuthentiKine Human VEGF ELISA Kit (KE00216, Proteintech, USA), Human CD40L ELISA Kit (ab99991, Abcam, USA).

    Techniques: MANN-WHITNEY, Derivative Assay

    Glioblastoma (GBM) secretes CD40L to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001

    Journal: Clinical and Translational Medicine

    Article Title: Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment

    doi: 10.1002/ctm2.997

    Figure Lengend Snippet: Glioblastoma (GBM) secretes CD40L to upregulate LOX expression via CD40 in MSLCs. (A) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) analysis in MSLC treatment control conditioned media (CM), X01 CM or astrocyte CM. (B) Cytokine array of X01 CM or astrocyte CM as indicated ( n = 2). (C) Densitometry analysis of cytokine array shown in (B). (D) qRT‐PCR for LOX and COL1A1 in MSLCs co‐cultured with X01 cells depleted of cytokine genes using siRNA. (E) qRT‐PCR for LOX and COL1A1 in MSLCs depleted of cytokine receptor gene using siRNA co‐cultured with X01. (F) Enzyme‐linked immunosorbent assay of LOX level in CM from (D) and (E). (G) Representative image of 3D collagen‐based matrix pre‐incubated with X01 cells transfected with siRNA‐control or si‐ CD40L and/or MSLCs transfected with siRNA‐control or si‐ CD40 stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (H) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ CD40 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. * p < .05, ** p < .01, *** p < .001, **** p < .0001

    Article Snippet: CM collected from each cell culture medium and the level of secreted LOX (MBS039099, MyBioSource, San Diego, CA, USA), Collagen1A1 (MBS763786, MyBioSource, San Diego, CA, USA) and CD40L (DCDL40, R&D system, MN, USA) were measured using ELISA according to the manufacturer's instructions.

    Techniques: Expressing, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Incubation, Transfection, Staining

    CD40L increased LOX expression via CD40‐mediated NF‐κB2 nucleus translocation. (A) Western blot analysis to determine CD40 downstream effector activation status in MSLCs treated with control conditioned medium (CM) or X01 CM. (B) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of LOX expression in MSLCs transfected with siRNA as indicated. (C) Western blot analysis of the nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM in the cytosol‐nuclear fraction of MSLCs. (D) Immunocytochemistry in MSLCs and nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM. Scale bar: 50 μm. (E) qRT‐PCR of LOX expression in MSLCs treated with X01 CM and transfected with siRNA as indicated. (F) Enzyme‐linked immunosorbent assay of LOX in CM after co‐culture with each transfected cell type. (G) Western blots of fractionated lysates of MSLCs transfected with siRNA‐control or si‐ CD40 after co‐culture with X01. (H) Nuclear translocation of NF‐κB2 in MSLC siRNA‐control or MSLC si‐ CD40 treated or not treated with X01 CM. Scale bar: 50 μm. (I) Chromatin immunoprecipitation for assessing NF‐κB2 binding to LOX promoter in MSLCs. (J) Representative image of 3D collagen‐based matrix pre‐incubated with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 and/or X01 cells stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Bottom graph shows collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (K) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. ** p < .01, *** p < .001, **** p < .0001

    Journal: Clinical and Translational Medicine

    Article Title: Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment

    doi: 10.1002/ctm2.997

    Figure Lengend Snippet: CD40L increased LOX expression via CD40‐mediated NF‐κB2 nucleus translocation. (A) Western blot analysis to determine CD40 downstream effector activation status in MSLCs treated with control conditioned medium (CM) or X01 CM. (B) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of LOX expression in MSLCs transfected with siRNA as indicated. (C) Western blot analysis of the nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM in the cytosol‐nuclear fraction of MSLCs. (D) Immunocytochemistry in MSLCs and nucleus translocation of NF‐κB1 or NF‐κB2 by X01 CM. Scale bar: 50 μm. (E) qRT‐PCR of LOX expression in MSLCs treated with X01 CM and transfected with siRNA as indicated. (F) Enzyme‐linked immunosorbent assay of LOX in CM after co‐culture with each transfected cell type. (G) Western blots of fractionated lysates of MSLCs transfected with siRNA‐control or si‐ CD40 after co‐culture with X01. (H) Nuclear translocation of NF‐κB2 in MSLC siRNA‐control or MSLC si‐ CD40 treated or not treated with X01 CM. Scale bar: 50 μm. (I) Chromatin immunoprecipitation for assessing NF‐κB2 binding to LOX promoter in MSLCs. (J) Representative image of 3D collagen‐based matrix pre‐incubated with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 and/or X01 cells stained with Picrosirius red. Image: bright field (top), collagen fibre (mid, polarized light), and analysis of polarized area (bottom). Bottom graph shows collagen fibre area = polarized area/total area ( n = 4). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. (K) X01 spheroid infiltration in 3D collagen‐based matrix co‐cultured with MSLCs transfected with siRNA‐control or si‐ NF‐κB2 . Bottom graph shows calculation results of the infiltration area. Scale bar: 200 μm. ** p < .01, *** p < .001, **** p < .0001

    Article Snippet: CM collected from each cell culture medium and the level of secreted LOX (MBS039099, MyBioSource, San Diego, CA, USA), Collagen1A1 (MBS763786, MyBioSource, San Diego, CA, USA) and CD40L (DCDL40, R&D system, MN, USA) were measured using ELISA according to the manufacturer's instructions.

    Techniques: Expressing, Translocation Assay, Western Blot, Activation Assay, Control, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Transfection, Immunocytochemistry, Enzyme-linked Immunosorbent Assay, Co-Culture Assay, Chromatin Immunoprecipitation, Binding Assay, Incubation, Staining, Cell Culture

    CD40L neutralizing antibody and knockdown of CD40 suppressed ECM remodelling and GBM infiltration. (A) Schematic illustration of GBM model generation and the overall therapeutic procedure for orthotopic xenograft animal model. (B) H&E and ZEB1 staining of coronally sectioned mouse brain. Yellow dash represents tumour margin. Red triangles represent ZEB1‐positive infiltration cells ( n = 6 mouse/group). Scale bar: 100 μm. (C) The number of ZEB1‐positive cells infiltrated outside the tumour margin in (B). (D) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of CD40L , CD40 and LOX expression in mouse brain tissue ( n = 3 mouse/group). (E) IHC of CD40, CD40L, NFκB2 and LOX in the indicated groups ( n = 6 mouse/group). Scale bar: 100 μm. (F) Representative image of Picrosirius red‐stained mouse brain tissue for each xenograft group. Collagen fibre area = polarized area/total area ( n = 6 mouse/group). Collagen fibre area (right) = polarized area/total area ( n = 6 mouse/group). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. *** p < .001, **** p < .0001

    Journal: Clinical and Translational Medicine

    Article Title: Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment

    doi: 10.1002/ctm2.997

    Figure Lengend Snippet: CD40L neutralizing antibody and knockdown of CD40 suppressed ECM remodelling and GBM infiltration. (A) Schematic illustration of GBM model generation and the overall therapeutic procedure for orthotopic xenograft animal model. (B) H&E and ZEB1 staining of coronally sectioned mouse brain. Yellow dash represents tumour margin. Red triangles represent ZEB1‐positive infiltration cells ( n = 6 mouse/group). Scale bar: 100 μm. (C) The number of ZEB1‐positive cells infiltrated outside the tumour margin in (B). (D) Quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) of CD40L , CD40 and LOX expression in mouse brain tissue ( n = 3 mouse/group). (E) IHC of CD40, CD40L, NFκB2 and LOX in the indicated groups ( n = 6 mouse/group). Scale bar: 100 μm. (F) Representative image of Picrosirius red‐stained mouse brain tissue for each xenograft group. Collagen fibre area = polarized area/total area ( n = 6 mouse/group). Collagen fibre area (right) = polarized area/total area ( n = 6 mouse/group). Bright field scale bar: 100 μm; polarized light scale bar: 10 μm. *** p < .001, **** p < .0001

    Article Snippet: CM collected from each cell culture medium and the level of secreted LOX (MBS039099, MyBioSource, San Diego, CA, USA), Collagen1A1 (MBS763786, MyBioSource, San Diego, CA, USA) and CD40L (DCDL40, R&D system, MN, USA) were measured using ELISA according to the manufacturer's instructions.

    Techniques: Knockdown, Animal Model, Staining, Reverse Transcription, Polymerase Chain Reaction, Quantitative RT-PCR, Expressing

    Correlation between tumour MSLC‐isolatable patients and clinical outcome. (A) IHC of LOX, COL1A1, CD40L, CD40 and NF‐κB2 in MSLC‐isolatable ( n = 4) and MSLC‐non‐isolatable ( n = 4) patient samples. Scale bar: 100 μm. (B) Picrosirius red‐stained MSLC‐isolatable ( n = 3) and MSLC‐non‐isolatable ( n = 3) GBM patient samples. Image: collagen fibre (top, polarized light) and analysis of polarized area (bottom). Graph shows collagen fibre area = polarized area/total area ( n = 3). (C) Gene set enrichment analysis (GSEA) of MSLC‐isolatable and non‐isolatable patients. Analysis of gene set related to ECM‐cell adhesion by each GBM subtype. (D) Kaplan–Meier survival curves of all glioma patients (REMBRANDT) with fixed high or low LOX and COL1A1 median expression. (E) GSEA of all GBMLGG patients with high and low median LOX expression. (F) GBM subtype‐specific expression of the indicated genes in patients with GBM in The Cancer Genome Atlas (TCGA). (G) Two‐gene scatter plots of the indicated genes in patients with glioma in TCGA. (H) Kaplan–Meier survival curves of all glioma patients (TCGA) with high or low indicated median expression of gene. (I) Schematic summarizing promotion of ECM remodelling and GBM infiltration by GBM‐educated MSLCs in the tumour microenvironment. n.s. = not significant, * p < .05, ** p < .01, **** p < .0001

    Journal: Clinical and Translational Medicine

    Article Title: Glioblastoma‐educated mesenchymal stem‐like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment

    doi: 10.1002/ctm2.997

    Figure Lengend Snippet: Correlation between tumour MSLC‐isolatable patients and clinical outcome. (A) IHC of LOX, COL1A1, CD40L, CD40 and NF‐κB2 in MSLC‐isolatable ( n = 4) and MSLC‐non‐isolatable ( n = 4) patient samples. Scale bar: 100 μm. (B) Picrosirius red‐stained MSLC‐isolatable ( n = 3) and MSLC‐non‐isolatable ( n = 3) GBM patient samples. Image: collagen fibre (top, polarized light) and analysis of polarized area (bottom). Graph shows collagen fibre area = polarized area/total area ( n = 3). (C) Gene set enrichment analysis (GSEA) of MSLC‐isolatable and non‐isolatable patients. Analysis of gene set related to ECM‐cell adhesion by each GBM subtype. (D) Kaplan–Meier survival curves of all glioma patients (REMBRANDT) with fixed high or low LOX and COL1A1 median expression. (E) GSEA of all GBMLGG patients with high and low median LOX expression. (F) GBM subtype‐specific expression of the indicated genes in patients with GBM in The Cancer Genome Atlas (TCGA). (G) Two‐gene scatter plots of the indicated genes in patients with glioma in TCGA. (H) Kaplan–Meier survival curves of all glioma patients (TCGA) with high or low indicated median expression of gene. (I) Schematic summarizing promotion of ECM remodelling and GBM infiltration by GBM‐educated MSLCs in the tumour microenvironment. n.s. = not significant, * p < .05, ** p < .01, **** p < .0001

    Article Snippet: CM collected from each cell culture medium and the level of secreted LOX (MBS039099, MyBioSource, San Diego, CA, USA), Collagen1A1 (MBS763786, MyBioSource, San Diego, CA, USA) and CD40L (DCDL40, R&D system, MN, USA) were measured using ELISA according to the manufacturer's instructions.

    Techniques: Staining, Expressing

    Expression of CD40L and 4-1BBL on Mel526 cells Mel526 cells infected with LOAd700 or LOAd703 express CD40L (upper histograms), while cells infected with LOAd703 also present 4-1BBL (lower histograms), as shown with flow cytometry at day 2 post-infection. Gray and black histograms represent isotype control and transgene staining, respectively.

    Journal: Molecular Therapy Oncolytics

    Article Title: Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

    doi: 10.1016/j.omto.2021.02.007

    Figure Lengend Snippet: Expression of CD40L and 4-1BBL on Mel526 cells Mel526 cells infected with LOAd700 or LOAd703 express CD40L (upper histograms), while cells infected with LOAd703 also present 4-1BBL (lower histograms), as shown with flow cytometry at day 2 post-infection. Gray and black histograms represent isotype control and transgene staining, respectively.

    Article Snippet: ELISA was performed using a human CD40L ELISA kit (ELH-CD40L) and a human 4-1BBL ELISA kit (ELH-41BBL) (RayBiotech).

    Techniques: Expressing, Infection, Flow Cytometry, Staining

    Characterization of exosomes (A) Nanoparticle tracking analysis of exosomes isolated from Mel 626 cells using NanoSight NS500. Captures 1–5 represent five captured videos for calculation of size and concentration of exosomes. (B) Exosomal markers (CD63 and CD81) were evaluated on cells (either infected or uninfected) and their exosomes using western blot. (C) Electron micrographs of isolated exosomes stained for CD40L or 4-1BBL. Arrows indicate positive staining. Cells exo, exosomes from uninfected cells; LOAd cells, cells infected with LOAd viruses; LOAd exo, exosomes released by LOAd-infected cells.

    Journal: Molecular Therapy Oncolytics

    Article Title: Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

    doi: 10.1016/j.omto.2021.02.007

    Figure Lengend Snippet: Characterization of exosomes (A) Nanoparticle tracking analysis of exosomes isolated from Mel 626 cells using NanoSight NS500. Captures 1–5 represent five captured videos for calculation of size and concentration of exosomes. (B) Exosomal markers (CD63 and CD81) were evaluated on cells (either infected or uninfected) and their exosomes using western blot. (C) Electron micrographs of isolated exosomes stained for CD40L or 4-1BBL. Arrows indicate positive staining. Cells exo, exosomes from uninfected cells; LOAd cells, cells infected with LOAd viruses; LOAd exo, exosomes released by LOAd-infected cells.

    Article Snippet: ELISA was performed using a human CD40L ELISA kit (ELH-CD40L) and a human 4-1BBL ELISA kit (ELH-41BBL) (RayBiotech).

    Techniques: Isolation, Concentration Assay, Infection, Western Blot, Staining

    CD40L and 4-1BBL protein content of cells and exosomes (A and B) Exosomes derived from Mel526 cells infected with LOAd viruses or left uninfected were investigated for the presence of CD40L (A) and 4-1BBL (B) with ELISA. Each group was tested in duplicate. Error bars represent standard error and median values are displayed in the graphs.

    Journal: Molecular Therapy Oncolytics

    Article Title: Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

    doi: 10.1016/j.omto.2021.02.007

    Figure Lengend Snippet: CD40L and 4-1BBL protein content of cells and exosomes (A and B) Exosomes derived from Mel526 cells infected with LOAd viruses or left uninfected were investigated for the presence of CD40L (A) and 4-1BBL (B) with ELISA. Each group was tested in duplicate. Error bars represent standard error and median values are displayed in the graphs.

    Article Snippet: ELISA was performed using a human CD40L ELISA kit (ELH-CD40L) and a human 4-1BBL ELISA kit (ELH-41BBL) (RayBiotech).

    Techniques: Derivative Assay, Infection, Enzyme-linked Immunosorbent Assay

    Surface expression of CD40L and 4-1BBL on exosomes from LOAd-infected cells using flow cytometry (A) Total percentage of CD40L + and 4-1BBL + exosomes. (B) Mean fluorescence intensity (MFI) of CD40L and 4-1BBL expression on CD63 + bead-coupled exosomes. ∗p ≤ 0.05, n = 3. Error bars represent standard error and median values are displayed in the graphs.

    Journal: Molecular Therapy Oncolytics

    Article Title: Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

    doi: 10.1016/j.omto.2021.02.007

    Figure Lengend Snippet: Surface expression of CD40L and 4-1BBL on exosomes from LOAd-infected cells using flow cytometry (A) Total percentage of CD40L + and 4-1BBL + exosomes. (B) Mean fluorescence intensity (MFI) of CD40L and 4-1BBL expression on CD63 + bead-coupled exosomes. ∗p ≤ 0.05, n = 3. Error bars represent standard error and median values are displayed in the graphs.

    Article Snippet: ELISA was performed using a human CD40L ELISA kit (ELH-CD40L) and a human 4-1BBL ELISA kit (ELH-41BBL) (RayBiotech).

    Techniques: Expressing, Infection, Flow Cytometry, Fluorescence

    TMZ-CD40L and 4-1BBL mRNA in infected cells and exosomes (copy number per picogram) (A and B) LOAd-infected or uninfected Mel526 cells and cell-derived exosomes were evaluated for their TMZ-CD40L (A) or 4-1BBL (B) mRNA content using quantitative real-time PCR. Samples were analyzed in triplicates (cells) or duplicates (exosomes). Statistical analyses were done using a Kruskal-Wallis test for non-parametric samples with a Dunn’s multi-comparison test. A p value of ≤0.05 was considered significant. n = 3.Error bars represent standard error and median values are displayed in the graphs.

    Journal: Molecular Therapy Oncolytics

    Article Title: Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

    doi: 10.1016/j.omto.2021.02.007

    Figure Lengend Snippet: TMZ-CD40L and 4-1BBL mRNA in infected cells and exosomes (copy number per picogram) (A and B) LOAd-infected or uninfected Mel526 cells and cell-derived exosomes were evaluated for their TMZ-CD40L (A) or 4-1BBL (B) mRNA content using quantitative real-time PCR. Samples were analyzed in triplicates (cells) or duplicates (exosomes). Statistical analyses were done using a Kruskal-Wallis test for non-parametric samples with a Dunn’s multi-comparison test. A p value of ≤0.05 was considered significant. n = 3.Error bars represent standard error and median values are displayed in the graphs.

    Article Snippet: ELISA was performed using a human CD40L ELISA kit (ELH-CD40L) and a human 4-1BBL ELISA kit (ELH-41BBL) (RayBiotech).

    Techniques: Infection, Derivative Assay, Real-time Polymerase Chain Reaction